The 1st Annual Meeting of the Middle-Eastern Association for Cancer Reseach: Cancer Research from Be (MEACR 2011 at Tanta )

Venue: Tanta University Convention Center

Location: Tanta, Gharbia, Egypt

Event Date/Time: Dec 27, 2011 End Date/Time: Dec 29, 2011
Registration Date: Dec 01, 2011
Early Registration Date: Oct 15, 2011
Abstract Submission Date: Dec 01, 2011
Paper Submission Date: Dec 15, 2011
Report as Spam


Tanta University and the Middle-Eastern Association for Cancer Research (MEACR) would like to invite you to participate in The 1st Annual Conference of the MEACR at Tanta University from 27-29/12/2011.

المؤتمر السنوى الأول لاتحاد الشرق أوسطى لأبحاث السرطان
بعنوان: الجديد فى أبحاث السرطان من البحث إلى التطبيق السريرى

The conference will discuss various themes in clinical and experimental cancer research, including
Cancer Angiogenesis Cancer Metastasis Chemotherapy
Cancer cell signaling Immunotherapy Nanotechnology
Tumor Markers Early detection Inflammation & cancer
Infection and cancer Carcinogenesis Apoptosis
Stem cells and Cancer Clinical trials Epidemiology
Medicinal plants Cancer genetics Gene therapy

Registration fees
Egyptians: 800 L. E. with paper 200 LE without a research paper
Non-Egyptians: $400 with a research paper $200 without a research paper
Accompanying: 200 LE Egyptians $100 Non-Egyptians

Fees include registration, stay for 2 nights at the hotel, lunch and dinner on 27th and 28th of December, coffee breaks, conference materials, and publications in the MEACR journal (Clinical Cancer Investigation, CCI) upon the authors’ request. If you need to stay more, it costs 150 L.E.

Call for Papers (deadline: 15/11/2011):
The deadline for abstract submission is November 15, 2011.
Abstracts (200-250 words) are to be submitted to:
Dr. Mohamed Labib Salem, Prof. of Immunology, Faculty of Science, Tanta University []; [] Tel: +20-0174272624, Fax: +20-40-3350804
Dr Ala Eldin Al-Mostafa []; []

Confirmed speakers:
• Mostafa Elsayed, PhD: Juilius Brown Chair and Regent Professor, Director, Laser Dynamics Lab, Georgia Tech, Atlanta, Georgia, USA. Nanoparticles in cancer diagnoses and therapy
• Mamdooh Ghoneum, MD, PhD: Charles Drew University of Medicine & Science, USA. From bench to bedside: The use of arabinoxylan rice bran (MGN-3/Biobran) in cancer medicine
• Abdel Rahman Nabawy Zekri, PhD: Head, Virology and Immunology Department, National Cancer Institute, Cancer Biology Unit, Cairo University, Egypt. Liver cancer
• Shahid Pervez, MD, PhD: Professor & Consultant Histopathology, Department of Pathology & Microbiology, Aga Khan University Hospital, Karachi, Pakistan. Precursor Lesions & Predictive markers of Oral Cancer
• Shengdian Wang, MD, PhD: Professor/Deputy Director; CAS Key Lab of Infection and Immunity Institute of Biophysics, Chinese Academy of Sciences. Improvement of Conventional Cancer Therapies by Manipulating Tumor Immunological Microenvironment
• Prof. Shafaat A. Rabbani, PhD: McGill University Health Centre, Department of Medicine, Montreal, Quebec, Canada.
• Prof. Mehmet Ozturk MD, PhD: Department of Molecular Biology and Genetics, Bilkent Ankara TURKEY. Molecular Mechanisms of Liver Cancer
• Malcolm Moore, PhD: Head, UICC Asian Regional Office, Chief Editor, Asian Pacific Journal of Cancer Prevention, Chief Editor APJCP, Head UICC Asian Regional Office. Preparing Scientific Manuscripts for Publication – Focus on the APJCP
• Pierre-Yves Desprez, Ph.D, Senior Scientist, California Pacific Medical Center, Cancer Research Institute, 475 Brannan Street, San Francisco, CA 94107, USA. Id Genes and Proteins as Novel Therapeutic Targets for Metastatic Cancer
• Hassan Azazi, PhD: Hassan M. E. Azzazy, PhD, SC(ASCP), DABCC, FAC: Professor of Chemistry, Leader, Novel Diagnostics & Therapeutics Research Group, School of Sciences & Engineering, The American University In Cairo, New Cairo, Egypt

Our words: We hope that this conference will lead to initiation of projects and collaboration between participants from different countries in cancer research for fruitful outcomes. We are looking for¬ward to your participation in our first meeting for a successful launch of MEACR’s initiation in ME countries.

For more information please visit:
Good luck and best wishes

Dr. Ala Eldin Al-Mostafa

Prof. Mohamed Labib Salem
Prof. of Immunology, Faculty of Science, Tanta University
Tel. +20-01274272624


Medical Campus